+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Joint Pain Injections Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2018-2026

  • ID: 4850999
  • Report
  • March 2019
  • Region: Global
  • 190 pages
  • Transparency Market Research
1 of 2

Joint Pain Injections Market: Overview

This report analyzes the current and future scenario of the global joint pain injections market for the period 2018 to 2026. Rise in geriatric population, increased prevalence of joint disorders, and high unmet medical needs are likely to be major drivers of the global joint pain injections market during the forecast period. 

The joint pain injections market report comprises an elaborate executive summary, including a snapshot that provides information on various segments of the market. It also provides information and data analysis of the global market with respect to segments based on injections type, joint, distribution channel, and region. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section. Additionally, the section comprises competitive matrix and profiles of key market players, along with business overview, to project the competitive landscape of the market. The section also provides market attractiveness analysis based on region and market share analysis in terms of key players, thereby presenting a thorough analysis of the overall competitive scenario in the joint pain injections market. 

Joint Pain Injections Market: Key Segments

Based on injection type, the global joint pain injections market has been segmented into corticosteroid injections, hyaluronic acid injections, and others. In terms of joint type, the global joint pain injections market has been divided into knee & ankle, hip joint, shoulder & elbow, facet joints of the spine, and others. Based on distribution channel, the market has been segregated into hospital pharmacies, retail pharmacies, and online pharmacies. The market size and forecast for each of these segments have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. 

Joint Pain Injections Market: Regional Outlook

In terms of region, the global joint pain injections market has been segmented into five major regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and Middle East & Africa (South Africa, GCC Countries, and Rest of Middle East & Africa). Market size and forecast for each of these regions and the mentioned countries have been provided for the period 2018 to 2026, along with their respective CAGR for the forecast period 2016 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario in these regions. 

Companies Mentioned in the Report

The report also profiles major players operating in the global joint pain injections market based on various attributes, such as company overview, financial overview, product portfolio, business strategies, and recent developments. The players covered in the report include Allergan Plc., Pfizer Inc., Sanofi, Anika Therapeutics, Inc., Ferring B.V., Bioventus, Flexion Therapeutics, Inc., Zimmer Biomet Holdings, Inc., SEIKAGAKU CORPORATION, and Chugai Pharmaceutical Co., Ltd. The global joint pain injections market has been segmented as below:

Note: Product cover images may vary from those shown
2 of 2
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Joint Pain Injections Market

4. Market Overview
4.1. Introduction
4.1.1. Injection Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Joint Pain Injections Market Analysis and Forecast, 2016-2026
4.4.1. Global Joint Pain Injections Market Revenue Projections (US$ Mn)

5. Market Outlook
5.1. Disease Prevalence & Incidence Rate Globally with Key Countries
5.2. Pipeline Analysis
5.3. Regulatory Scenario, by Region/Globally

6. Global Joint Pain Injections Market Analysis and Forecast, by Injection Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Global Joint Pain Injections Market Value Forecast, by Injection Type, 2016-2026
6.3.1. Corticosteroid Injections
6.3.2. Hyaluronic Acid Injections
6.3.3. Others
6.4. Global Joint Pain Injections Market Attractiveness, by Injection Type

7. Global Joint Pain Injections Market Analysis and Forecast, by Joint Type
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Global Joint Pain Injections Market Value Forecast, by Joint Type, 2016-2026
7.3.1. Knee & Ankle
7.3.2. Hip Joint
7.3.3. Shoulder & Elbow
7.3.4. Facet Joints of the Spine
7.3.5. Others
7.4. Global Joint Pain Injections Market Attractiveness, by Joint Type

8. Global Joint Pain Injections Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Global Joint Pain Injections Market Value Forecast, by Distribution Channel, 2016-2026
8.3.1. Hospital Pharmacies
8.3.2. Retail Pharmacies
8.3.3. Online Pharmacies
8.4. Global Joint Pain Injections Market Attractiveness, by Distribution Channel

9. Global Joint Pain Injections Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Global Joint Pain Injections Market Value Forecast, by Region
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Global Joint Pain Injections Market Attractiveness, by Region

10. North America Joint Pain Injections Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. North America Joint Pain Injections Market Value Forecast, by Injection Type, 2016-2026
10.2.1. Corticosteroid Injections
10.2.2. Hyaluronic Acid Injections
10.2.3. Others
10.3. North America Joint Pain Injections Market Value Forecast, by Joint Type, 2016-2026
10.3.1. Knee & Ankle
10.3.2. Hip Joint
10.3.3. Shoulder & Elbow
10.3.4. Facet Joints of the Spine
10.3.5. Others
10.4. North America Joint Pain Injections Market Value Forecast, by Distribution Channel, 2016-2026
10.4.1. Hospital Pharmacies
10.4.2. Retail Pharmacies
10.4.3. Online Pharmacies
10.5. North America Joint Pain Injections Market Value Forecast, by Country, 2016-2026
10.5.1. U.S.
10.5.2. Canada
10.6. North America Joint Pain Injections Market Attractiveness Analysis
10.6.1. By Injection Type
10.6.2. By Joint Type
10.6.3. By Distribution Channel
10.6.4. By Country

11. Europe Joint Pain Injections Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Europe Joint Pain Injections Market Value Forecast, by Injection Type, 2016-2026
11.2.1. Corticosteroid Injections
11.2.2. Hyaluronic Acid Injections
11.2.3. Others
11.3. Europe Joint Pain Injections Market Value Forecast, by Joint Type, 2016-2026
11.3.1. Knee & Ankle
11.3.2. Hip Joint
11.3.3. Shoulder & Elbow
11.3.4. Facet Joints of the Spine
11.3.5. Others
11.4. Europe Joint Pain Injections Market Value Forecast, by Distribution Channel, 2016-2026
11.4.1. Hospital Pharmacies
11.4.2. Retail Pharmacies
11.4.3. Online Pharmacies
11.5. Europe Joint Pain Injections Market Value Forecast, by Country/Sub-region, 2016-2026
11.5.1. Germany
11.5.2. U.K.
11.5.3. France
11.5.4. Spain
11.5.5. Italy
11.5.6. Rest of Europe
11.6. Europe Joint Pain Injections Market Attractiveness Analysis
11.6.1. By Injection Type
11.6.2. By Joint Type
11.6.3. By Distribution Channel
11.6.4. By Country/Sub-region

12. Asia Pacific Joint Pain Injections Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Asia Pacific Joint Pain Injections Market Value Forecast, by Injection Type, 2016-2026
12.2.1. Corticosteroid Injections
12.2.2. Hyaluronic Acid Injections
12.2.3. Others
12.3. Asia Pacific Joint Pain Injections Market Value Forecast, by Joint Type, 2016-2026
12.3.1. Knee & Ankle
12.3.2. Hip Joint
12.3.3. Shoulder & Elbow
12.3.4. Facet Joints of the Spine
12.3.5. Others
12.4. Asia Pacific Joint Pain Injections Market Value Forecast, by Distribution Channel, 2016-2026
12.4.1. Hospital Pharmacies
12.4.2. Retail Pharmacies
12.4.3. Online Pharmacies
12.5. Asia Pacific Joint Pain Injections Market Value Forecast, by Country/Sub-region, 2016-2026
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Asia Pacific Joint Pain Injections Market Attractiveness Analysis
12.6.1. By Injection Type
12.6.2. By Joint Type
12.6.3. By Distribution Channel
12.6.4. By Country/Sub-region

13. Latin America Joint Pain Injections Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Latin America Joint Pain Injections Market Value Forecast, by Injection Type, 2016-2026
13.2.1. Corticosteroid Injections
13.2.2. Hyaluronic Acid Injections
13.2.3. Others
13.3. Latin America Joint Pain Injections Market Value Forecast, by Joint Type, 2016-2026
13.3.1. Knee & Ankle
13.3.2. Hip Joint
13.3.3. Shoulder & Elbow
13.3.4. Facet Joints of the Spine
13.3.5. Others
13.4. Latin America Joint Pain Injections Market Value Forecast, by Distribution Channel, 2016-2026
13.4.1. Hospital Pharmacies
13.4.2. Retail Pharmacies
13.4.3. Online Pharmacies
13.5. Latin America Joint Pain Injections Market Value Forecast, by Country/Sub-region, 2016-2026
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Latin America Joint Pain Injections Market Attractiveness Analysis
13.6.1. By Injection Type
13.6.2. By Joint Type
13.6.3. By Distribution Channel
13.6.4. By Country/Sub-region

14. Middle East & Africa Joint Pain Injections Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Middle East & Africa Joint Pain Injections Market Value Forecast, by Injection Type, 2016-2026
14.2.1. Corticosteroid Injections
14.2.2. Hyaluronic Acid Injections
14.2.3. Others
14.3. Middle East & Africa Joint Pain Injections Market Value Forecast, by Joint Type, 2016-2026
14.3.1. Knee & Ankle
14.3.2. Hip Joint
14.3.3. Shoulder & Elbow
14.3.4. Facet Joints of the Spine
14.3.5. Others
14.4. Middle East & Africa Joint Pain Injections Market Value Forecast, by Distribution Channel, 2016-2026
14.4.1. Hospital Pharmacies
14.4.2. Retail Pharmacies
14.4.3. Online Pharmacies
14.5. Middle East & Africa Joint Pain Injections Market Value Forecast, by Country/Sub-region, 2016-2026
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Injection Type
14.6.2. By Joint Type
14.6.3. By Distribution Channel
14.6.4. By Country/Sub-region

15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Company Profiles
15.2.1. Pfizer Inc.
15.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.1.2. Product Portfolio
15.2.1.3. SWOT Analysis
15.2.1.4. Financial Overview
15.2.1.5. Strategic Overview
15.2.2. Sanofi
15.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.2.2. Product Portfolio
15.2.2.3. SWOT Analysis
15.2.2.4. Financial Overview
15.2.2.5. Strategic Overview
15.2.3. Anika Therapeutics, Inc.
15.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.3.2. Product Portfolio
15.2.3.3. SWOT Analysis
15.2.3.4. Financial Overview
15.2.3.5. Strategic Overview
15.2.4. Ferring B.V.
15.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.4.2. Product Portfolio
15.2.4.3. SWOT Analysis
15.2.4.4. Financial Overview
15.2.4.5. Strategic Overview
15.2.5. Bioventus
15.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.5.2. Product Portfolio
15.2.5.3. SWOT Analysis
15.2.5.4. Financial Overview
15.2.5.5. Strategic Overview
15.2.6. Flexion Therapeutics, Inc.
15.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.6.2. Product Portfolio
15.2.6.3. SWOT Analysis
15.2.6.4. Financial Overview
15.2.6.5. Strategic Overview
15.2.7. Zimmer Biomet Holdings, Inc.
15.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.7.2. Product Portfolio
15.2.7.3. SWOT Analysis
15.2.7.4. Financial Overview
15.2.7.5. Strategic Overview
15.2.8. SEIKAGAKU CORPORATION
15.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.8.2. Product Portfolio
15.2.8.3. SWOT Analysis
15.2.8.4. Financial Overview
15.2.8.5. Strategic Overview
15.2.9. Chugai Pharmaceutical Co., Ltd.
15.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.2.9.2. Product Portfolio
15.2.9.3. SWOT Analysis
15.2.9.4. Financial Overview
15.2.9.5. Strategic Overview
Note: Product cover images may vary from those shown
3 of 2

Loading
LOADING...

Adroll
adroll